Imexpharm Balance Sheet

Financials in millions VND. Fiscal year is January - December.

Millions VND. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Jan '25 Jan 1, 2025	Jan '24 Jan 1, 2024	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	156,814	189,193	161,983	106,201	178,845	271,273
Short-Term Investments	346,672	212,102	142,000	93,000	211,300	111,300
Trading Asset Securities	-	-	-	-	-	1,153
Cash & Short-Term Investments	503,486	401,296	303,983	199,201	390,145	383,726
Cash Growth	-7.45%	32.01%	52.60%	-48.94%	1.67%	157.75%
Accounts Receivable	449,468	323,278	334,746	254,058	228,770	241,946
Other Receivables	8,147	4,036	4,030	4,066	-1,000	11,995
Receivables	457,615	327,314	338,776	258,124	227,770	255,941
Inventory	670,022	677,715	705,082	699,446	435,841	492,075
Prepaid Expenses	-	21,304	15,564	6,539	1,601	3,155
Other Current Assets	53,024	79,783	46,139	43,825	48,195	41,443
Total Current Assets	1,684,146	1,507,411	1,409,544	1,207,135	1,103,553	1,176,340
Property, Plant & Equipment	721,607	745,246	828,489	908,754	996,450	955,680
Long-Term Investments	97,088	66,959	66,959	71,284	71,290	50,962
Other Intangible Assets	71,933	73,215	74,219	74,150	72,978	73,581
Other Long-Term Assets	1,054	389,804	125,566	131,293	32,672	38,136
Total Assets	2,946,667	2,782,634	2,504,777	2,392,615	2,276,944	2,294,700
Accounts Payable	90,791	80,783	77,044	70,505	87,542	92,713
Accrued Expenses	127,964	102,784	89,231	144,776	139,803	100,346
Short-Term Debt	95,178	112,779	86,122	49,422	-	80,491
Current Portion of Long-Term Debt	-	-	-	-	94,980	91,652
Current Income Taxes Payable	23,930	27,727	31,631	19,107	25,382	17,141
Current Unearned Revenue	35,874	-	-	-	-	-
Other Current Liabilities	128,188	48,360	37,630	24,227	34,789	26,295
Total Current Liabilities	501,924	372,432	321,657	308,036	382,497	408,638
Long-Term Debt	100,000	100,000	-	-	-	91,652
Other Long-Term Liabilities	3,680	3,680	-	-	-	-
Total Liabilities	605,604	476,112	321,657	308,036	382,497	500,290
Common Stock	1,540,428	1,540,428	1,540,428	700,384	667,054	667,054
Additional Paid-In Capital	187,323	187,323	187,323	507,368	507,368	507,368
Retained Earnings	611,249	576,709	453,306	874,764	717,963	617,926
Treasury Stock	-358.6	-358.6	-358.6	-358.6	-358.6	-358.6
Comprehensive Income & Other	2,421	2,421	2,421	2,421	2,421	2,421
Shareholders' Equity	2,341,063	2,306,522	2,183,119	2,084,579	1,894,447	1,794,410
Total Liabilities & Equity	2,946,667	2,782,634	2,504,777	2,392,615	2,276,944	2,294,700
Total Debt	195,178	212,779	86,122	49,422	94,980	263,795
Net Cash (Debt)	308,308	188,516	217,862	149,779	295,165	119,931
Net Cash Growth	121.07%	-13.47%	45.46%	-49.26%	146.11%	568.18%
Net Cash Per Share	2001.88	1224.06	1414.60	972.53	1916.53	778.71
Filing Date Shares Outstanding	154.01	154.01	154.01	154.01	154.01	154.01
Total Common Shares Outstanding	154.01	154.01	154.01	154.01	154.01	154.01
Working Capital	1,182,222	1,134,979	1,087,886	899,099	721,056	767,702
Book Value Per Share	15200.82	14976.55	14175.27	13535.33	12300.70	11651.16
Tangible Book Value	2,269,130	2,233,308	2,108,900	2,010,429	1,821,469	1,720,829
Tangible Book Value Per Share	14733.75	14501.15	13693.36	13053.86	11826.85	11173.39
Buildings	385,562	385,312	384,650	384,597	299,061	298,602
Machinery	1,120,768	1,101,466	1,088,549	1,066,310	638,041	601,972
Construction In Progress	42,881	37,418	43,897	47,351	580,743	519,463